Steven Stromsdorfer
Psychiatry · Saint Louis, MONPI 1851362479
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 686 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 686 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$2K
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$961
- Lundbeck LLC$957
- Johnson & Johnson$809
- plus $4K from 24 others
What the payments were for
- Food & beverage$11,491100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 91 | $1,695 |
| AbbVie(2 entities) | 114 | $1,592 |
| Otsuka America Pharmaceutical, Inc. | 69 | $1,169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 70 | $961 |
| Lundbeck LLC | 60 | $957 |
| Johnson & Johnson | 41 | $809 |
| Vanda Pharmaceuticals Inc. | 38 | $783 |
| Sunovion Pharmaceuticals Inc. | 57 | $648 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $445 |
| Axsome Therapeutics, Inc. | 26 | $423 |
| Teva Pharmaceuticals USA, Inc. | 8 | $348 |
| Alkermes, Inc. | 17 | $264 |
| Neurocrine Biosciences, Inc. | 14 | $244 |
| Supernus Pharmaceuticals, Inc. | 11 | $181 |
| Jazz Pharmaceuticals Inc. | 7 | $120 |
| Ironshore Pharmaceuticals Inc. | 6 | $106 |
| Eisai Inc. | 7 | $98 |
| Avanir Pharmaceuticals, Inc. | 5 | $96 |
| Harmony Biosciences LLC | 2 | $81 |
| Noven Therapeutics, LLC | 5 | $75 |
| Almatica Pharma LLC | 4 | $71 |
| Idorsia Pharmaceuticals US Inc | 4 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Tris Pharma Inc | 2 | $38 |
| Vertical Pharmaceuticals, LLC | 2 | $31 |
| Adlon Therapeutics L.p. | 2 | $29 |
| Shire North American Group Inc | 2 | $28 |
| Indivior Inc. | 1 | $25 |
| Alfasigma USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,501 in reported general payments places this provider in the 90th percentile of 680 psychiatry providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 22 | $25,084 |
| TrintellixVortioxetine Hydrobromide | 34 | $20,385 |
| AuvelityDextromethorphan Hbr/Bupropion | 14 | $13,408 |
| Lurasidone Hcl | 14 | $12,617 |
| Vilazodone Hcl | 59 | $4,232 |
| Quetiapine Fumarate | 142 | $4,049 |
| Aripiprazole | 61 | $3,031 |
| Duloxetine Hcl | 147 | $2,753 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 64 | $2,743 |
| Ramelteon | 22 | $2,613 |
| Alprazolam | 366 | $2,321 |
| Clonazepam | 174 | $2,274 |
| Phenelzine Sulfate | 19 | $1,853 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 66 | $1,768 |
| Lisdexamfetamine Dimesylate | 12 | $1,690 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,592 | $25,08422 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $961 | $20,38534 claims |
| Axsome Therapeutics, Inc.Auvelity | $423 | $13,40814 claims |
| Almatica Pharma LLCSertraline Hcl | $71 | $790144 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 680 psychiatry providers in Missouri.
Other psychiatry in Saint Louis
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- George GrossbergSaint Louis$501K
- Christopher LoyndSaint Louis$265K
- Devnandini RastogiSaint Louis$261K
- Michael StotlerSaint Louis$250K
- James ChoSaint Louis$118K
- Steven HarveySaint Louis$90K
- Kevin BlackSaint Louis$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.